News

Shockwave Medical Completes Acquisition of Neovasc

SANTA CLARA, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV) (“Shockwave”), a pioneer in the development…

2 years ago

CERIS’ “The Pulse of Payment Integrity” Outlines New Claims Processing Path For Payers

Strengthening Process Boosts Revenue, Improves Provider RelationsFORT WORTH, Texas, April 11, 2023 (GLOBE NEWSWIRE) -- CERIS, a CorVel company, has…

2 years ago

MitWellness introduces New Patent for 100% Food Grade Kratom Extract

MitWellness, through its sister company, MitSciences, has developed a patent-pending kratom extraction process utilizing all food-grade solvents resulting in a…

2 years ago

Guy De La Rosa, MD, Joins Curevo Vaccine as Chief Medical Officer

Dr. De La Rosa adds over 20 years of big pharma and biotech infectious disease clinical trial experience to Curevo…

2 years ago

Generation Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference 

CAMBRIDGE, Mass., April 11, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people…

2 years ago

Celebrating National Medical Laboratory Week at LifeLabs

Toronto, April 10, 2023 (GLOBE NEWSWIRE) -- LifeLabs is excited to recognize and celebrate our 7,000+ talented and dedicated lab…

2 years ago

Hillstream BioPharma Announces Pharmacokinetic Data of HSB-1216 Supportive of its Development Strategy and Pre-clinical Data

In IND-enabling studies, HSB-1216 remained tightly bound within the Quatramer™ until reaching its tumor target, consistent with earlier pre-clinical studies…

2 years ago

Healthcare Triangle Closes $500,000 Private Placement of Common Stock Priced Above The Market

PLEASANTON, Calif., April 10, 2023 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the "Company"), a leader in…

2 years ago

Cerevance to Present at the Needham Healthcare Conference

BOSTON, April 10, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on central nervous…

2 years ago

Acceptance of CPP-1X (DFMO) Abstract for Poster Presentation at Immunology of Diabetes Society Meeting

MINNEAPOLIS, April 10, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics…

2 years ago